BeStock  
Markets › Compare › SMMT vs INSM

SMMT vs INSM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SMMT · Summit Therapeutics$17.29 ▲ 2.25%
INSM · Insmed$110.96 ▼ 2.79%

Head to head

MetricSMMTINSM
Price$17.29$110.96
Change today▲ 2.25%▼ 2.79%
Market cap$13.79B$24.23B
Return, 3 months–+3.7%
Return, year to date–-36.2%
Return, 1 year–-24.7%
P/E (TTM)-15.6-26.9
P/B21.932.0
P/E percentile vs own 5y–8th
Dividend yield––
Revenue growth (YoY, latest qtr)–+296.1%
Net profit growth (YoY)–+95.9%
Gross margin–83.5%
Operating margin–-71.4%
Net margin–-76.9%
Return on equity–-87.2%
Analyst target vs. price+71.1%+78.6%
Analyst buy share67%100%
RSI (14)–39
30-day volatility–35.4%
Max drawdown, 1 year–-56.5%
Trend read–Strong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • INSM is the largest of the group by market value.
  • INSM carries the lowest trailing P/E.

Go deeper

Scroll to Top